GO
Loading...

Government Agencies

More

  • Dec 22- The U.S. Food and Drug Administration approved Bristol-Myers Squibb Co's skin cancer drug, more than three months before the scheduled review date. The drug is the second PD-1 inhibitor to be approved by the FDA, the first being Merck& Co Inc's Keytruda in September. The FDA was scheduled to review the drug on March 30.

  • FDA approves Bristol-Myer's skin cancer drug Monday, 22 Dec 2014 | 2:32 PM ET

    Dec 22- The U.S. Food and Drug Administration granted an accelerated approval to Bristol-Myers Squibb Co's drug for an advanced form of skin cancer. The drug, Opdivo, inhibits the action of the protein PD-1, which prevents the body's immune system from attacking melanoma tumors. The FDA's approval comes well before its scheduled review date of March 30.

  • WASHINGTON, Dec 22- The U.S. Commodity Futures Trading Commission on Monday ordered Deutsche Bank to pay a $3 million fine over charges that it had failed to properly invest customer funds and had made other mistakes in the process. Deutsche Bank neither denied nor admitted the regulator's findings, a court order said. In July, the Federal Reserve Bank of New York...

  • WASHINGTON, Dec 22- The U.S. Commodity Futures Trading Commission on Monday ordered a unit of Deutsche Bank to pay a $3 million fine over charges that it had failed to properly invest customer funds and had made other mistakes in the process. "DBSI failed to accurately compute the amount of customer funds on deposit," over the period of June 18, 2012 to August 15, 2012,...

  • The Justice Department said Alstom paid more than $75 million to secure $4 billion in projects around the world. DOJ said Alstom pleaded guilty to a two-count criminal information filed in a federal court in Connecticut and that Alstom's Swiss unit also pleaded guilty to criminal charges that it conspired to violate federal bribery laws.

  • Dec 22- The U.S. Food and Drug Administration approved Biocryst Pharmaceuticals Inc's intravenous flu drug, sending the company's shares up nearly 10 percent in premarket trading. The single-dose drug is for adults who have acute uncomplicated influenza and may be unable to swallow pills, such as Gilead Sciences Inc's Tamiflu, or inhale GlaxoSmithKline...

  • FDA approves BioCryst's flu shot Monday, 22 Dec 2014 | 5:04 AM ET

    Dec 22- The U.S. Food and Drug Administration approved Biocryst Pharmaceuticals Inc's single-dose flu shot on Monday, for use in adults with acute uncomplicated influenza. The drug was developed under a $234.8 million contract from Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services.

  • Dec 19- U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12- week plan, a bit below its huge selling competitor Solvadi from Gilead Sciences. AbbVie's newly approved regimen is also less costly than Gilead's newest one-pill regimen that combines Sovaldi with...

  • NEW YORK, Dec 19- The U.S. dollar hit its highest level against major currencies in over 8-1/ 2 years on Friday on diverging monetary policy between the Federal Reserve and other major central banks, and bullish dollar positions heading into the end of the year. The euro hit a 28- month low against the greenback, while the dollar hovered near a 28- month high against...

  • Dec 19- U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, providing the first competition for Gilead Sciences huge selling and expensive medicine for the liver-destroying virus. The AbbVie regimen consists of four different anti-viral drugs to be taken as three pills in the morning and one in the evening.

  • Dec 19- The U.S. Environmental Protection Agency issued rules on Friday labeling coal ash, a byproduct of coal-based power production containing toxic materials such as arsenic and lead, as non-hazardous waste. The label means that states, and not the EPA, will be the primary enforcers of the new rules, which will require the closure of some coal ash holding ponds...

  • National Labor Relations Board on Friday filed complaints against McDonald's Corp and its franchises for alleged labor violations, including the illegal firing and intimidation of staff who protested working conditions. NLRB General Counsel Richard Griffin filed complaints in 78 cases against the company and its franchisees from New York to Los...

  • Dec 19- A lawyer from the U.S. National Labor Relations Board on Friday filed complaints against McDonald's Corp and its franchisees for alleged labor violations. NLRB General Counsel Richard Griffin filed 13 complaints against the company and its franchisees from New York to Los Angeles, the board said.

  • NATIONAL LABOR RELATIONS BOARD OFFICIAL ISSUES COMPLAINTS AGAINST MCDONALDS FOR ALLEGED LABOR VIOLATIONS BY FRANCHISEES- FILING.

  • Dec 19- AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after it was approved by the European Commission. An advisory panel to the U.S. Food and Drug Administration had voted in June against granting an accelerated approval to the drug, Lynparza, citing inadequate data. Lynparza aims to treat...

  • U.S. settles lawsuit with T-Mobile US over cramming Friday, 19 Dec 2014 | 12:12 PM ET

    WASHINGTON, Dec 19- T-Mobile US has agreed to settle a lawsuit filed by the U.S. government over unauthorized charges placed on customers' bills, a practice known as cramming, and to pay at least $90 million in refunds and fines, two U.S. government agencies said on Friday. T-Mobile USA received 35 to 40 percent of the amount charged, the Federal Trade Commission said...

  • *Asia shares buoyed as Wall St surges for second day. SYDNEY, Dec 19- Asian shares enjoyed their best day in 15 months on Friday, after Wall Street boasted its biggest two-day advance since late 2011 amid relief the Federal Reserve was in no rush to withdraw stimulus from the U.S. economy. MSCI's broadest index of Asia-Pacific shares outside Japan put on 1.5 percent,...

  • *Asia shares buoyed as Wall St surges for second day. SYDNEY, Dec 19- Japanese stocks led Asian markets higher on Friday, after Wall Street boasted its biggest two-day advance since late 2011 amid relief the Federal Reserve was in no rush to start hiking interest rates. In Asia, Japan's Nikkei climbed 1.9 percent to erase much of it's recent losses, while Australia's...

  • GLOBAL MARKETS-Asian stocks catch Wall St tailwind Thursday, 18 Dec 2014 | 6:26 PM ET

    SYDNEY, Dec 19- Asian markets looked set for another upbeat session on Friday after Wall Street boasted its biggest two-day advance since late 2011 amid relief the Federal Reserve was in no rush to start hiking interest rates. Brent was quoted $1.37 lighter at $59.81 a barrel, while U.S. crude was hovering around $55.00 after losing more than $2 on Thursday.

  • The greenback hit a 28- month high against the Swiss franc at 0.9847 franc after the Swiss National Bank said it would impose an interest rate of -0.25 percent on some large deposits held by investors in francs, as it seeks to discourage buying of the currency as a safe haven. The euro hit its lowest level against the dollar since Dec. 8, at $1.2266, while the dollar...